Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steen Stender

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
British Journal of Clinical Pharmacology|July 27, 2005
Statin use after acute myocardial infarction: a nationwide study in DenmarkJeppe N Rasmussen, Gunnar H Gislason, Steen Z Abildstrom, et al.
Contact Dermatitis|December 21, 2010
Nickel reactivity and filaggrin null mutations--evaluation of the filaggrin bypass theory in a general populationKatrine Ross-Hansen, Torkil Menné, Jeanne D Johansen, et al.
European Heart Journal|January 10, 2006
Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarctionGunnar H Gislason, Jeppe N Rasmussen, Steen Z Abildstrøm, et al.
British Journal of Clinical Pharmacology|March 15, 2011
Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treated chronic heart-failure patientsMorten Petersen, Jon T Andersen, Brian R Hjelvang, et al.
Pharmacogenetics and Genomics|July 5, 2012
Effect of specific ADRB1/ADRB2/AGT genotype combinations on the association between survival and carvedilol treatment in chronic heart failure: a substudy of the ECHOS trialMorten Petersen, Jon T Andersen, Espen Jimenez-Solem, et al.
Journal of Lipid Research|July 29, 2011
Effect of industrially produced trans fat on markers of systemic inflammation: evidence from a randomized trial in womenNathalie T Bendsen, Steen Stender, Pal B Szecsi, et al.
BMJ Open|October 25, 2011
A possible association between a dysfunctional skin barrier (filaggrin null-mutation status) and diabetes: a cross-sectional studyJacob P Thyssen, Allan Linneberg, Berit C Carlsen, et al.
Scandinavian Cardiovascular Journal : SCJ|August 16, 2005
Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002Gunnar H Gislason, Steen Z Abildstrom, Jeppe N Rasmussen, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 2015
New Nordic Diet-Induced Weight Loss Is Accompanied by Changes in Metabolism and AMPK Signaling in Adipose TissueAndreas Mæchel Fritzen, Anne-Marie Lundsgaard, Andreas Børsting Jordy, et al.
Diabetes/Metabolism Research and Reviews|May 19, 2011
Effects of different protein content and glycaemic index of ad libitum diets on diabetes risk factors in overweight adults: the DIOGenes multicentre, randomized, dietary intervention trialEstibaliz Goyenechea, Claus Holst, Marleen A van Baak, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
British Journal of Clinical Pharmacology|July 27, 2005
Statin use after acute myocardial infarction: a nationwide study in DenmarkJeppe N Rasmussen, Gunnar H Gislason, Steen Z Abildstrom, et al.
Contact Dermatitis|December 21, 2010
Nickel reactivity and filaggrin null mutations--evaluation of the filaggrin bypass theory in a general populationKatrine Ross-Hansen, Torkil Menné, Jeanne D Johansen, et al.
European Heart Journal|January 10, 2006
Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarctionGunnar H Gislason, Jeppe N Rasmussen, Steen Z Abildstrøm, et al.
British Journal of Clinical Pharmacology|March 15, 2011
Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treated chronic heart-failure patientsMorten Petersen, Jon T Andersen, Brian R Hjelvang, et al.
Pharmacogenetics and Genomics|July 5, 2012
Effect of specific ADRB1/ADRB2/AGT genotype combinations on the association between survival and carvedilol treatment in chronic heart failure: a substudy of the ECHOS trialMorten Petersen, Jon T Andersen, Espen Jimenez-Solem, et al.
Journal of Lipid Research|July 29, 2011
Effect of industrially produced trans fat on markers of systemic inflammation: evidence from a randomized trial in womenNathalie T Bendsen, Steen Stender, Pal B Szecsi, et al.
BMJ Open|October 25, 2011
A possible association between a dysfunctional skin barrier (filaggrin null-mutation status) and diabetes: a cross-sectional studyJacob P Thyssen, Allan Linneberg, Berit C Carlsen, et al.
Scandinavian Cardiovascular Journal : SCJ|August 16, 2005
Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002Gunnar H Gislason, Steen Z Abildstrom, Jeppe N Rasmussen, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 2015
New Nordic Diet-Induced Weight Loss Is Accompanied by Changes in Metabolism and AMPK Signaling in Adipose TissueAndreas Mæchel Fritzen, Anne-Marie Lundsgaard, Andreas Børsting Jordy, et al.
Diabetes/Metabolism Research and Reviews|May 19, 2011
Effects of different protein content and glycaemic index of ad libitum diets on diabetes risk factors in overweight adults: the DIOGenes multicentre, randomized, dietary intervention trialEstibaliz Goyenechea, Claus Holst, Marleen A van Baak, et al.
Pageof 11